MUSC Health began offering SAINT (Stanford Neuromodulation Therapy) in 2024, providing an accelerated TMS protocol that MUSC reports produces ~80% remission by day five and a mean time to remission of 2.6 days for treatment-resistant depression.
Read moreA 25-year scientometric analysis charts global publication and citation patterns for vagus nerve stimulation in psychiatric research, highlighting where academic attention and research output have concentrated over the past quarter-century.
Read moreA March 26, 2026 paper in Cyborg and Bionic Systems reports a visual SSVEP BCI that averaged 472.7 bits/min online and hit a 551.4 bpm individual peak using hybrid frequency–phase–space encoding and a 66-parieto‑occipital high-density EEG setup.
Read moreA review synthesizes modeling work across DBS, spinal cord, vagus and peripheral nerve interfaces and recommends combining high-fidelity biophysical simulations with fast surrogate 'digital twin' models to speed device design and personalized stimulation. The authors call for more in vivo validation, standardized reporting, and open-source pipelines to bridge lab models and clinical programming.
Read moreRecipients of experimental brain implants report restored speech and robotic control but highlight practical limits: wired lab systems, decoder recalibration, surgical risks and short trial windows.
Read moreEndometriosis Surgical Specialists International (ESSI) argues parasympathetic activation should be integrated into standard care for endometriosis, chronic pelvic pain and related GI symptoms, recommending a tailored menu from breathing and pelvic-floor therapy to tVNS and gut-directed CBT.
Read more